<!DOCTYPE html>
<html lang="en-us">

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.4.0">

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Tim Kacprowski">

  
  
  
    
  
  <meta name="description" content="Determinations of thyrotropin (TSH) and free thyroxine (FT4) represent the gold standard in evaluation of thyroid function. To screen for novel peripheral biomarkers of thyroid function and to characterize FT4-associated physiological signatures in human plasma we used an untargeted OMICS approach in a thyrotoxicosis model. A sample of 16 healthy young men were treated with levothyroxine for 8 weeks and plasma was sampled before the intake was started as well as at two points during treatment and after its completion, respectively. Mass spectrometry-derived metabolite and protein levels were related to FT4 serum concentrations using mixed-effect linear regression models in a robust setting. To compile a molecular signature discriminating between thyrotoxicosis and euthyroidism, a random forest was trained and validated in a two-stage cross-validation procedure. Despite the absence of obvious clinical symptoms, mass spectrometry analyses detected 65 metabolites and 63 proteins exhibiting significant associations with serum FT4. A subset of 15 molecules allowed a robust and good prediction of thyroid hormone function (AUC = 0.86) without prior information on TSH or FT4. Main FT4-associated signatures indicated increased resting energy expenditure, augmented defense against systemic oxidative stress, decreased lipoprotein particle levels, and increased levels of complement system proteins and coagulation factors. Further association findings question the reliability of kidney function assessment under hyperthyroid conditions and suggest a link between hyperthyroidism and cardiovascular diseases via increased dimethylarginine levels. Our results emphasize the power of untargeted OMICs approaches to detect novel pathways of thyroid hormone action. Furthermore, beyond TSH and FT4, we demonstrated the potential of such analyses to identify new molecular signatures for diagnosis and treatment of thyroid disorders. This study was registered at the German Clinical Trials Register (DRKS) [DRKS00011275] on the 16th of November 2016.">

  
  <link rel="alternate" hreflang="en-us" href="/publication/pietzner-et-al.-2017/">

  


  

  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.6.0/css/all.css" integrity="sha384-aOkxzJ5uQz7WBObEZcHvV5JvRW3TUc2rNPA7pe3AwnsUohiw1Vj2Rgx2KSOkF5+h" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    

    

  

  
  
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700|Roboto:400,400italic,700|Roboto+Mono&display=swap">
  

  
  
  
  <link rel="stylesheet" href="/css/academic.min.863679108eccaa86b806f7003d41cf89.css">

  

  
  
  

  

  <link rel="manifest" href="/index.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon-32.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="/publication/pietzner-et-al.-2017/">

  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary">
  
  <meta property="og:site_name" content="ResGro CompSysMed">
  <meta property="og:url" content="/publication/pietzner-et-al.-2017/">
  <meta property="og:title" content="Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model | ResGro CompSysMed">
  <meta property="og:description" content="Determinations of thyrotropin (TSH) and free thyroxine (FT4) represent the gold standard in evaluation of thyroid function. To screen for novel peripheral biomarkers of thyroid function and to characterize FT4-associated physiological signatures in human plasma we used an untargeted OMICS approach in a thyrotoxicosis model. A sample of 16 healthy young men were treated with levothyroxine for 8 weeks and plasma was sampled before the intake was started as well as at two points during treatment and after its completion, respectively. Mass spectrometry-derived metabolite and protein levels were related to FT4 serum concentrations using mixed-effect linear regression models in a robust setting. To compile a molecular signature discriminating between thyrotoxicosis and euthyroidism, a random forest was trained and validated in a two-stage cross-validation procedure. Despite the absence of obvious clinical symptoms, mass spectrometry analyses detected 65 metabolites and 63 proteins exhibiting significant associations with serum FT4. A subset of 15 molecules allowed a robust and good prediction of thyroid hormone function (AUC = 0.86) without prior information on TSH or FT4. Main FT4-associated signatures indicated increased resting energy expenditure, augmented defense against systemic oxidative stress, decreased lipoprotein particle levels, and increased levels of complement system proteins and coagulation factors. Further association findings question the reliability of kidney function assessment under hyperthyroid conditions and suggest a link between hyperthyroidism and cardiovascular diseases via increased dimethylarginine levels. Our results emphasize the power of untargeted OMICs approaches to detect novel pathways of thyroid hormone action. Furthermore, beyond TSH and FT4, we demonstrated the potential of such analyses to identify new molecular signatures for diagnosis and treatment of thyroid disorders. This study was registered at the German Clinical Trials Register (DRKS) [DRKS00011275] on the 16th of November 2016."><meta property="og:image" content="/img/icon-192.png">
  <meta property="twitter:image" content="/img/icon-192.png"><meta property="og:locale" content="en-us">
  
    
      <meta property="article:published_time" content="2017-01-01T00:00:00&#43;01:00">
    
    <meta property="article:modified_time" content="2017-01-01T00:00:00&#43;01:00">
  

  

<link rel="stylesheet" href="//cdnjs.cloudflare.com/ajax/libs/cookieconsent2/3.0.3/cookieconsent.min.css">
<script src="https://cdnjs.cloudflare.com/ajax/libs/cookieconsent2/3.0.3/cookieconsent.min.js"></script>
<script>
  window.addEventListener("load", function(){
    window.cookieconsent.initialise({
      "palette": {
        "popup": {
          "background": "#2962ff",
          "text": "#fff"
        },
        "button": {
          "background": "#fff",
          "text": "#2962ff"
        }
      },
      "theme": "classic",
      "content": {
        "message": "This website uses cookies to ensure you get the best experience on our website.",
        "dismiss": "Got it!",
        "link": "Learn more",
        "href": "https://cookies.insites.com"
      }
    })});
</script>



  





  <title>Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model | ResGro CompSysMed</title>

</head>

<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" >

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  
<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0 compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/">ResGro CompSysMed</a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav ml-auto">
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#posts"><span><b>News</b></span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#people"><span><b>Team</b></span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#projects"><span><b>Projects</b></span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#publications"><span><b>Publications</b></span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#softress"><span><b>Software & Resources</b></span></a>
        </li>

        
        

      

        

        

        

        
        <li class="nav-item">
          <a href="https://www.tum.de" target="_blank">
            <img src="/img/TUM_Web_Logo_blau.png" alt="TUM" style="margin-top:12px;margin-left:12px;">
          </a>
        </li>

      </ul>

    </div>
  </div>
</nav>


  <div class="pub" itemscope itemtype="http://schema.org/CreativeWork">

  












  

  
  
  
<div class="article-container pt-3">
  <h1 itemprop="name">Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model</h1>

  

  
    



<meta content="2017-01-01 00:00:00 &#43;0100 CET" itemprop="datePublished">
<meta content="2017-01-01 00:00:00 &#43;0100 CET" itemprop="dateModified">

<div class="article-metadata">

  
  
  
  
  <div>
    



  <span itemprop="author name" itemtype="http://schema.org/Person"><a href="/authors/m.-pietzner/">M. Pietzner</a></span>, <span itemprop="author name" itemtype="http://schema.org/Person"><a href="/authors/b.-engelmann/">B. Engelmann</a></span>, <span itemprop="author name" itemtype="http://schema.org/Person"><a href="/authors/t.-kacprowski/"><strong>T. Kacprowski</strong></a></span>, <span itemprop="author name" itemtype="http://schema.org/Person"><a href="/authors/et-al./"><em>et al.</em></a></span>, <span itemprop="author name" itemtype="http://schema.org/Person"><a href="/authors/g.-homuthsup2/sup/">G. Homuth<!-- raw HTML omitted -->2<!-- raw HTML omitted --></a></span>, <span itemprop="author name" itemtype="http://schema.org/Person"><a href="/authors/g.-brabantsup2/sup/">G. Brabant<!-- raw HTML omitted -->2<!-- raw HTML omitted --></a></span>

  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    <time>January 2017</time>
  </span>
  

  

  

  
  
  

  
  

  
    
<div class="share-box" aria-hidden="true">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=/publication/pietzner-et-al.-2017/&amp;text=Plasma%20proteome%20and%20metabolome%20characterization%20of%20an%20experimental%20human%20thyrotoxicosis%20model" target="_blank" rel="noopener" class="share-btn-twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=/publication/pietzner-et-al.-2017/&amp;t=Plasma%20proteome%20and%20metabolome%20characterization%20of%20an%20experimental%20human%20thyrotoxicosis%20model" target="_blank" rel="noopener" class="share-btn-facebook">
          <i class="fab fa-facebook-f"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Plasma%20proteome%20and%20metabolome%20characterization%20of%20an%20experimental%20human%20thyrotoxicosis%20model&amp;body=/publication/pietzner-et-al.-2017/" target="_blank" rel="noopener" class="share-btn-email">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=/publication/pietzner-et-al.-2017/&amp;title=Plasma%20proteome%20and%20metabolome%20characterization%20of%20an%20experimental%20human%20thyrotoxicosis%20model" target="_blank" rel="noopener" class="share-btn-linkedin">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://web.whatsapp.com/send?text=Plasma%20proteome%20and%20metabolome%20characterization%20of%20an%20experimental%20human%20thyrotoxicosis%20model%20/publication/pietzner-et-al.-2017/" target="_blank" rel="noopener" class="share-btn-whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=/publication/pietzner-et-al.-2017/&amp;title=Plasma%20proteome%20and%20metabolome%20characterization%20of%20an%20experimental%20human%20thyrotoxicosis%20model" target="_blank" rel="noopener" class="share-btn-weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>


  

</div>

    














  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract" itemprop="text">Determinations of thyrotropin (TSH) and free thyroxine (FT4) represent the gold standard in evaluation of thyroid function. To screen for novel peripheral biomarkers of thyroid function and to characterize FT4-associated physiological signatures in human plasma we used an untargeted OMICS approach in a thyrotoxicosis model. A sample of 16 healthy young men were treated with levothyroxine for 8 weeks and plasma was sampled before the intake was started as well as at two points during treatment and after its completion, respectively. Mass spectrometry-derived metabolite and protein levels were related to FT4 serum concentrations using mixed-effect linear regression models in a robust setting. To compile a molecular signature discriminating between thyrotoxicosis and euthyroidism, a random forest was trained and validated in a two-stage cross-validation procedure. Despite the absence of obvious clinical symptoms, mass spectrometry analyses detected 65 metabolites and 63 proteins exhibiting significant associations with serum FT4. A subset of 15 molecules allowed a robust and good prediction of thyroid hormone function (AUC = 0.86) without prior information on TSH or FT4. Main FT4-associated signatures indicated increased resting energy expenditure, augmented defense against systemic oxidative stress, decreased lipoprotein particle levels, and increased levels of complement system proteins and coagulation factors. Further association findings question the reliability of kidney function assessment under hyperthyroid conditions and suggest a link between hyperthyroidism and cardiovascular diseases via increased dimethylarginine levels. Our results emphasize the power of untargeted OMICs approaches to detect novel pathways of thyroid hormone action. Furthermore, beyond TSH and FT4, we demonstrated the potential of such analyses to identify new molecular signatures for diagnosis and treatment of thyroid disorders. This study was registered at the German Clinical Trials Register (DRKS) [DRKS00011275] on the 16th of November 2016.</p>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            
            
            <a href="/publication/#2">
              Journal article
            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9"><em>BMC Med</em></div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    


    








  
  
    
  
  





  
  
  
  
  <div class="media author-card" itemscope itemtype="http://schema.org/Person">
    

    <div class="media-body">
      <h5 class="card-title" itemprop="name"><a href="/authors/m.-pietzner/"></a></h5>
      
      
      <ul class="network-icon" aria-hidden="true">
        
      </ul>
    </div>
  </div>




    


  </div>
</div>



      

    
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/highlight.min.js" integrity="sha256-aYTdUrn6Ow1DDgh5JTc3aDGnnju48y/1c8s1dgkYPQ8=" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/languages/r.min.js"></script>
        
      

      
      
    

    
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    

    
    

    

    
    

    
    

    
    

    
    
    
    
    
    
    
    
    
    
    
    
    <script src="/js/academic.min.dc856155b640fa1cd8bd8b7b068fe79c.js"></script>

    






  
  <div class="container">
    <footer class="site-footer">
  

  <p class="powered-by">
    

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" id="back_to_top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

  </div>
  

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

</body>
</html>
